Home > News > From Flameout to Bargain
July 8th, 2004
From Flameout to Bargain
The stock of biopharmaceutical and Merrill Lynch (NYSE: MER) Nanotech Index (AMEX: NNZ) member Flamel Technologies (Nasdaq: FLML) has declined more than 50% since hitting a $43.60 all-time high in September. The stock, down 11% today on no discernible news, is not matching the 20% increase, since May, of its index peers. Although the recent stock flameout might be an indication of trouble, a closer look reveals a lot to like.
Aspen Aerogels, Inc. Schedules Second Quarter 2014 Earnings Release and Conference Call July 15th, 2014
Nanometrics to Announce Second Quarter Financial Results on July 30, 2014 July 9th, 2014
Small, but heading for the big time: Nanobiotix revenue for the 1st quarter of 2014 and new composition of the shareholding May 12th, 2014
Harris & Harris Group Reports Financial Statements as of March 31, 2014 May 8th, 2014